Skip to main content

Interim reports

2019-11-19
AGREEMENTS IN JAPAN AND THE REPUBLIC OF KOREA
2019-08-29
EXECUTING ACCORDING TO PLAN WITH FOCUS ON MOB-015
2019-05-14
DIVESTED OTC BUSINESS - TIME FOR MOBERG PHARMA 2.0
2019-02-12
MAJOR TRANSFORMATION OF THE COMPANY AFTER A STRONG YEAR This year-end report 2018 is made public in advance due to the transaction press release announced earlier today regarding the divestment of Moberg Pharma’s OTC-business.